SEC Form 4 · accession 0001140361-26-029181
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Warren Nighan Jr.
Officer — SVP Quality and Regulatory
Period of report
Jul 16, 2026
Accepted (ET)
Jul 21, 2026 · 8:21 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 16, 2026 | F | 2,153 | $14.14 | D | 67,750 | D | |
| Common StockF2 | Jul 17, 2026 | F | 1,373 | $13.51 | D | 66,377 | D | |
| Common StockF3 | Jul 20, 2026 | F | 251 | $13.71 | D | 66,126 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The exempt disposition of 2,153 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.
- F2The exempt disposition of 1,373 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
- F3The exempt disposition of 251 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.